| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8930082 | British Journal of Anaesthesia | 2017 | 10 Pages |
Abstract
We identified concordance between the clinician diagnosis and screening tool outcomes for LANSS, DN4 and PDQ in patients with cancer pain. Shortcomings in relation to standardized clinician assessment are likely to account for variation in screening tool sensitivity, which should include the use of the neuropathic pain grading system. Further research is needed to standardize and improve clinical assessment in patients with cancer pain. Until the standardization of clinical diagnosis for neuropathic cancer pain has been validated, screening tools offer a practical approach to identify potential cases of neuropathic cancer pain.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
M.R. Mulvey, E.G. Boland, D. Bouhassira, R. Freynhagen, J. Hardy, M.J. Hjermstad, S. Mercadante, C. Pérez, M.I. Bennett,